Latest imports
$5.1MReported valueHS6 Product Import Market
CRI imports of Nucleic acids and their salts, other heterocyclic compounds, n.e.c. in heading number 2934 (HS 293499)
A complete buyer-market view for HS 293499, covering reported demand, import growth, supplier countries, market concentration, trade routes, and historical context.
Three-year growth
+10.9%Annualized changeSupplier countries
25Latest reported countMarket concentration
3309.85HHI indicatorMarket evidence
How large is the CRI HS 293499 market?
This profile combines the buyer market's reported size and growth with supplier and route observations for Nucleic acids and their salts, other heterocyclic compounds, n.e.c. in heading number 2934.
| Measure | Reported value | What it indicates |
|---|---|---|
| Latest imports | $5.1M | Import value in the latest available year |
| Three-year annualized growth | +10.9% | Change in reported import value |
| Three-year average imports | $5.4M | Average reported annual import value |
| Supplier countries | 25 | Distinct suppliers reported in the latest period |
| Market concentration | 3309.85 | HHI indicator based on supplier shares |
| Demand momentum | Growing demand | Direction reported for this market |
Supplier evidence
Who supplies CRI?
Leading supplier routes for this product and importing country, ranked by latest reported trade value.
| Supplier | Route trade | Three-year growth | Market share | Trend | Attention |
|---|---|---|---|---|---|
| Supplier route observations are not available. | |||||
Market reading
What does this buyer market show?
CRI reported imports of nucleic acids and their salts, other heterocyclic compounds, n.e.c. in heading number 2934 at $5.1M in the latest available observation, with three-year annualized change of +10.9%.
How to use this view
Compare supplier scale, market share, and growth together. A large supplier is not automatically a growing supplier, and a growing market does not guarantee commercial access.
Interpretation
How to assess this buyer market
Start with the size of reported imports, then compare the pace of change with supplier breadth. A concentrated market may be harder to enter but can reveal established supply relationships; a broad supplier base may offer more room for differentiated positioning.
Compare the route, not only the country
Supplier totals describe the market at country level. Route evidence can reveal which exporter-to-importer relationships account for the observed value and where supplier activity is changing.
Product classification
What does HS 293499 include?
HS 293499 covers Nucleic acids and their salts, other heterocyclic compounds, n.e.c. in heading number 2934. This page describes the six-digit Harmonized System classification and reported merchandise imports, not company-level sales or individual shipments.
The classification belongs to HS chapter 29 and heading 2934. Use the code when comparing this market with related product classifications.
How to interpret this market
Compare demand, suppliers, and routes together
CRI's reported imports of nucleic acids and their salts, other heterocyclic compounds, n.e.c. in heading number 2934 show the size of the buyer market. Supplier breadth and concentration add context, while route-level observations show which exporter-to-importer relationships account for the reported value.
A growing market does not guarantee commercial access, and a large supplier is not automatically the fastest-growing supplier. Read the current value together with the historical coverage, supplier share, and trend indicators.
Source and date
Reported merchandise-trade observations for HS6 293499. Coverage shown on this page: 1995-2024.
Definitions
Market share and growth are calculated from reported values where available. “Not reported” means the value was unavailable for this view.
Related view
Read the methodology before comparing markets.